Special Populations in PHEs (I): Paediatrics

15th July 2020
16:00 - 17:00


This webinar examines the evolving challenges to paediatrics during a PHE, specifically during this COVID-19 pandemic.

It addresses the following questions:

  1. How do we approach paediatric clinical research and pharmaceutical medicine during a PHE? Should our approach change?
  2. What are the real needs for children’s health during a PHE and how should pharmaceutical medicine respond?
  3. What regulatory and ethical considerations needs to be reviewed for paediatric clinical research during a PHE?

Preparedness training webinar series

This webinar is part of our series on Preparedness Planning for Public Health Emergencies.

Find out more.

Meet the speakers

Professor Mark Turner, Neonatology and Research Delivery, University of Liverpool & Co-coordinator of the IMI2 Project, Connect 4 Children, Collaborative Network for Clinical Trials for Children (c4c), United Kingdom


  • Professor Barbara Bierer, Multi-Regional Clinical Trial Center, Brigham and Women’s Hospital and Harvard University, USA

    Professor Mariana Kruger, Department of Paediatrics and Child Health, Stellenbosch University, South Africa

  • Professor Sidnei Epelman, Director, Pediatric Oncology Department, Santa Marcelina Hospital; Founder and President, TUCCA Association for Children and Adolescents with Cancer, INCTR São Paulo, Brazil

This webinar is free to attend

  • IMPORTANT: If you are unable to complete your booking online, please email fpm@fpm.org.uk and we will book you onto the event.
  • This event is approved for CPD.

See our Terms & Conditions for booking and please note our privacy policy.

Joining instructions will be sent to attendees no earlier than Tuesday 14 July 2020.


If you have any queries, please email fpm@fpm.org.uk.

To find out about sponsorship opportunities for this series please email Will Strange at w.strange@fpm.org.uk